Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Prot# A3921024: A Long-Term, Open-Label Follow -Up Study of CP-690,550, A Moderately Selective Janus-Kinase-3 Inhibitor, For Treatment of Rheumatoid Arthritis
Ruderman, Eric M
(PD/PI)
Medicine, Rheumatology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/10/08
→
4/10/11
Funding
ICON Clinical Research, LLC
(A3921024)
Pfizer Inc.
(A3921024)
View all
View less